Jing Liu, MD, PhD

?

Titles

Associate Professor of Department of Infectious Diseases

Committee member of Infectious Disease Society, Guangdong Preventive Medicine Association

?

Research Interests

Liver injury and liver regeneration

Natural history of HBV and HCV infection and anti-virus therapy

B cellular immunity of Hepatitis C

?

Education and Experience

Education

2010-2013 MD, PhD, the Sun Yat-sen University, thesis: “B cellular immunity of Hepatitis C”.

2004-2007 Master, the Sun Yat-sen University, thesis: “Natural History of HBV infection : Spontaneous decrease of HBV DNA”.

1994-1999 Bachelor, Medical School of Nanchang University.

Experience

2014-present Associate Professor, Department of Infectious Diseases, the 3rd Affiliated Hospital of Sun Yat-sen University

2014-2015 Visiting Scholar, Feinberg Medical School of Northwestern University, US, thesis: “Liver injury and liver regeneration”.

2009-2014 Attending Doctor, Department of Infectious Diseases, the 3rd Affiliated Hospital of Sun Yat-sen University

2007-2009 Residency, Department of Infectious Diseases, the 3rd Affiliated Hospital of Sun Yat-sen University

1999-2004 Residency, Department of Infectious Diseases, Infectious Diseases Hospital of Nanchang.

?

Honor and Award

The Excellent Graduate Students Prize of the Sun Yat-sen University, China, 2012

?

Publications

1. Jing Liu^#, Zi-de Deng*, Yue Wu, Jun-qiang Xie, Liang Peng, Zhi-liang Gao. The epidemiological features of spontaneous decrease of HBV DNA level in CHB/LC patients. Chin J Infect Dis, 2009, 27(4):228-233.

2. Jing Liu^#, Chao-shuang Lin, San-hong Hu, Mei-ling Liang, Zhi-xin Zhao, Zhi-liang Gao*. Quality of life in patients with chronic hepatitis C after PEG-Interferon a-2a therapy. Chin J Hepatol, 2011, 19(12):890-893.

3. Jing Liu^#, Chao-shuang Lin^#, Wei-qiang Gan, Yu-bao Zheng, Zhi-liang Gao*. Effect of healthcare insurance policy on the quality of life of chronic hepatitis C patients receiving interferon α-2a plus ribavirin therapy. Experimental and Therapeutic Medicine, 2012, 3: 1062-1066.

4. Jing Liu^#, Ting Liu, Yuan-kai Wu, Wei-min Ke, Zi-de Deng*, Zhi-liang Gao. Dynamic change of hepatitis B surface antigen expression in chronic hepatitis B patients during the natural recovery course and the short-term antivirus treatment. Chin J Hepatol, 2013, 21(8):575-579.

5. Jing Liu^#, Zhen Xu, Wen-Xiong Xu, Zhi-Shuo Mo, Xiang Zhu, Zhi-Liang Gao*. Role of BAFF/BLyS in Prediction of Rapid Virological Response to PEG-IFN α-2a plus Ribavirin in Patients with Chronic Hepatitis C. Hepatology, 2013(Supplement): Epub ahead of print.

6. Jing Liu^#, Zhe-bin Wu, Zhi-shuo Mo, Qing-Xian Cai, Xiang Zhu, Zhi-Liang Gao*. B-lymphocyte stimulator (BLys) and HCV genotype or IL28B SNPs for prediction of rapid virologic response in patients with chronic hepatitis C. Journal of Hepatology, 2013(Supplement), 58: S349.

7. Jing Liu^#, Qing-Xian Cai, Xiang Zhu, Zhi-shuo Mo, Zhe-bin Wu, Zhi-Liang Gao*. B activating factor (BAFF) and IFNγor IP10 for prediction of rapid virological response in patients with chronic hepatitis C. Journal of Hepatology, 2013(Supplement), 58: S349.

8. Liang Peng^#, Jing Liu^#, Yang-mei Li^#, Zhan-Lian Huang, Pei-pei Wang, Yu-rong Gu, Yu-bao Zheng and Zhi-liang Gao*. Serum proteomics analysis and comparisons using Itraq in the progression of hepatitis B. Experimental and Therapeutic Medicine, 2013, 6: 1169-1176.

9. Jian Zhang^#, Jing Liu^#, Yong Liu, Weibin Wu, Xiaojun Li, Yonghui Wu, Huiguo Chen, Kai Zhang, Lijia Gu*. miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12. Biomedicine & Pharmacotherapy 74(2015):215-221.

10. Jian Zhang^#, Jing Liu^#, Jianning Chen, Xiaojun Li, Yonghui Wu, Huiguo Chen, Weibin Wu, Kai Zhang, Lijia Gu*. Angiotensin receptor blockers (ARBs) reduce the risk of lung cancer: a systematic review and meta-analysis. Int J Clin Exp Med 2015;8(8):12656-12660.

11. Liang Peng^#, Jing Liu^#, Yang-mei Li^#, Zhan-lian Huang, Pei-pei Wang, Yu-bao Zheng, Yun-peng Hua, Zhi-liang Gao*. iTRAQ-based proteomic analysis of hepatic tissues from patients with HBV-induced acute on chronic liver failure. Experimental and Therapeutic Medicine, 2015, 10: 1732-1742.

Note: ^# Co-first author, * Corresponding author

?

Contact

Department of Infectious Diseases

The 3rd Affiliated Hospital of Sun Yat-sen University

600, Tianhe Road, Guangzhou, China

Phone: 86-20-85252372

Mobil Phone: 86-13556051920
Fax: 86-20-85252250

?